Growing Demand and Adoption of Preclinical Multimodal Devices to Boost Small Animal Imaging Market to USD 1.58 Billion by 2020

Growing Demand and Adoption of Preclinical Multimodal Devices to Boost Small Animal Imaging Market to USD 1.58 Billion by 2020

The global small animal imaging market is estimated to reach USD 1.58 Billion in 2020, growing at a CAGR of 9.6% from 2016 to 2020, according to a new market research report Small Animal Imaging Market 2016-2020, published by iHealthcareAnalyst, Inc.

Visit the Small Animal Imaging Market 2016-2020 report at https://www.ihealthcareanalyst.com/report/small-animal-imaging-market/

The global small animal imaging market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

Small animal imaging has been recognized as an important tool in preclinical research. Small animal imaging devices have proved efficient for the diagnoses of a variety of disease conditions found in laboratory animals. These devices are used in various domains such as cancer cell research, monitoring the drug response during drug development, biomarker research in animal models and others.

The global small animal imaging market segmentation is based on device types (Micro-CT imaging, micro-MRI imaging, micro-PET/SPECT imaging, multimodal imaging, optical imaging, micro-ultrasound imaging, micro-PAT imaging), reagent types (CT contrast reagents, MRI contrast reagent, nuclear imaging contrast reagents, optical imaging contrast reagents, ultrasound contrast reagents), application areas ( Oncology, Cardiology, Autoimmune diseases, Neurology and Psychiatry, Metabolic disorders, Pulmonary disorders and infectious disorders). The global small animal imaging market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Device Type 
1.1Micro-CT Imaging
1.2 Micro- MRI Imaging
1.3 Micro-PET/SPECT Imaging
1.4 Multimodal Imaging
1.5 Optical Imaging
1.6 Micro-Ultrasound Imaging
1.7 Micro-PAT Imaging

2. Reagent Type
2.1 Computed Tomography (CT) Contrast Reagents
2.2 MRI Contrast Reagents
2.3 Nuclear Imaging Contrast Reagents
2.4 Optical Imaging Contrast Reagents
2.5 Ultrasound Contrast Reagents

3. Application 
3.1 Oncology
3.2 Cardiology
3.3 Autoimmune Diseases
3.4 Neurology and Psychiatry
3.5 Others (Metabolic Disorders, Pulmonary Disorders and Infectious Disorders)

4. Geography (Region, Country)
4.1 North America (U.S., Canada)
4.2 Latin America (Brazil, Mexico, Rest of LA)
4.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4 Asia Pacific (Japan, China, India, Rest of APAC)
4.5 Rest of the World

5. Company Profiles
5.1 Agilent Technologies, Inc.
5.2 Aspect Imaging
5.3 Bruker Corporation
5.4 TriFoil Imaging, Inc.
5.5 LI-COR Biosciences, Inc.
5.6 FujiFilm VisualSonics, Inc.
5.7 Miltenyi Biotec GmbH
5.8 Perkin Elmer, Inc.
5.9 Promega Corporation
5.10 Siemens AG
5.11 SCANCO Medical AG
5.12 Targeson, Inc. 

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2016-10-14T06:19:19+00:00 Categories: Press Releases|